Aligos Therapeutics (ALGS) EBT (2019 - 2026)
Aligos Therapeutics (ALGS) reported EBT of -$22.7 million for Q1 2026, down 152.68% on a YoY basis from $43.1 million in Q1 2025, and down 14.47% quarter-over-quarter from -$19.9 million in Q4 2025.
Aligos Therapeutics (ALGS) EBT (2019 - 2026) Analysis & Trends
Aligos Therapeutics has reported EBT for 8 years, with the latest figure at -$22.7 million in Q1 2026.
- For the quarter ending Q1 2026, EBT fell 152.68% year-over-year to -$22.7 million; the trailing twelve-month figure through Mar 2026 stood at -$89.7 million (down 69.6% YoY), and the FY2025 full-year result was -$23.9 million, up 81.76% from the prior year.
- EBT for Q1 2026 stood at -$22.7 million, down from -$19.9 million in the prior quarter.
- The five-year high for EBT was $43.1 million in Q1 2025, with the low at -$82.1 million in Q4 2024.
- Historically, EBT has averaged -$21.2 million across 5 years, with a median of -$19.9 million in 2022.
- The largest YoY upside for EBT was 223.8% in 2025 against a maximum downside of 398.63% in 2025.
- Aligos Therapeutics' EBT stood at -$21.8 million in 2022, then decreased by 27.87% to -$27.9 million in 2023, then sank by 194.12% to -$82.1 million in 2024, then soared by 75.83% to -$19.9 million in 2025, then dropped by 14.47% to -$22.7 million in 2026.
- The last three EBT figures came in at -$22.7 million (Q1 2026), -$19.9 million (Q4 2025), and -$31.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -15.31 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.18 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -56.48 Mn |
| 10 | Aligos Therapeutics | 51.70 Mn | -28.13 Mn | - | -22.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.72 Mn |
| Dec 31, 2025 | -19.85 Mn |
| Sep 30, 2025 | -31.48 Mn |
| Jun 30, 2025 | -15.68 Mn |
| Mar 31, 2025 | 43.13 Mn |
| Dec 31, 2024 | -82.12 Mn |
| Sep 30, 2024 | -19.17 Mn |
| Jun 30, 2024 | 5.25 Mn |
| Mar 31, 2024 | -34.84 Mn |
| Dec 31, 2023 | -27.92 Mn |
| Sep 30, 2023 | -18.01 Mn |
| Jun 30, 2023 | -18.03 Mn |
| Mar 31, 2023 | -22.92 Mn |
| Dec 31, 2022 | -21.84 Mn |
| Sep 30, 2022 | -18.66 Mn |
| Jun 30, 2022 | -19.88 Mn |
| Mar 31, 2022 | -35.56 Mn |
| Dec 31, 2021 | -37.77 Mn |
| Sep 30, 2021 | -33.00 Mn |
| Jun 30, 2021 | -29.79 Mn |